FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076391217> ?p ?o ?g. }

• W2076391217 endingPage "207" @default.
• W2076391217 startingPage "201" @default.
• W2076391217 abstract "Increasing numbers of individuals are traveling to areas of high hepatitis A endemicity and require immunization against the hepatitis A virus (HAV). The option of using a virosomal, aluminum-free, HAV vaccine (Epaxal) for booster immunization following primary vaccination with an aluminum-adsorbed vaccine has been assessed.In total, 142 healthy subjects, 79 men and 63 women, aged 12 to 72 years, were injected intramuscularly with a booster dose of Epaxal (0.5 mL containing < or =500 RIA units of HAV antigen) 6 to 24 months after primary vaccination with Havrix (0.5 or 1.0 mL containing 720 or 1440 ELISA units of HAV antigen, respectively, adsorbed onto aluminum hydroxide). Anti-HAV antibody titers were measured on days 0 and 28 by an enzyme immunoassay. Adverse events were recorded for 1 month postinjection.Overall, 98/118 subjects (83%) with no serologic evidence of past HAV infection were still seroprotected at enrolment (anti-HAV antibody titer < or = 20 mIU/mL). The seroprotection rate was 87% in those primed with Havrix 1440 6 to 12 months earlier (n=93) and 60% in those primed < or =12 months before enrolment (n=20, mean 16 months). The geometric mean anti-HAV antibody titer increased from 65 mIU/mL at day 0 to 1,722 mIU/mL at day 28 after a single booster dose with Epaxal in evaluable subjects who were primarily vaccinated with either a single dose of Havrix 1440 (n=111) or two separate doses of Havrix 720 (n=4). All subjects were seroprotected at day 28, and 98% showed at least a four-fold increase in anti-HAV antibody titer. Epaxal was well tolerated and no serious adverse events were reported. At day 28, the tolerability of the vaccination was judged as either very good or good by 96% of vaccinees and by all investigators.Epaxal can be successfully used to boost immunization following primary vaccination with an aluminum-adsorbed vaccine, and is well tolerated." @default.
• W2076391217 created "2016-06-24" @default.
• W2076391217 creator A5009880582 @default.
• W2076391217 creator A5023970736 @default.
• W2076391217 creator A5053578134 @default.
• W2076391217 creator A5069017206 @default.
• W2076391217 date "2006-03-08" @default.
• W2076391217 modified "2023-10-05" @default.
• W2076391217 title "Immunogenicity of Booster Vaccination with a Virosomal Hepatitis A Vaccine after Primary Immunization with an Aluminum-adsorbed Hepatitis A Vaccine" @default.
• W2076391217 cites W144790324 @default.
• W2076391217 cites W1970731370 @default.
• W2076391217 cites W1987559094 @default.
• W2076391217 cites W1997359705 @default.
• W2076391217 cites W2003274213 @default.
• W2076391217 cites W2006666558 @default.
• W2076391217 cites W2007081564 @default.
• W2076391217 cites W2008207205 @default.
• W2076391217 cites W2018943646 @default.
• W2076391217 cites W2022162992 @default.
• W2076391217 cites W2023871112 @default.
• W2076391217 cites W2029390312 @default.
• W2076391217 cites W2030291525 @default.
• W2076391217 cites W2032314051 @default.
• W2076391217 cites W2032342497 @default.
• W2076391217 cites W2043046475 @default.
• W2076391217 cites W2046192256 @default.
• W2076391217 cites W2047511961 @default.
• W2076391217 cites W2062549441 @default.
• W2076391217 cites W2068099587 @default.
• W2076391217 cites W2099610577 @default.
• W2076391217 cites W2104449452 @default.
• W2076391217 cites W2108563400 @default.
• W2076391217 cites W2152869702 @default.
• W2076391217 cites W2158459008 @default.
• W2076391217 cites W4231860838 @default.
• W2076391217 cites W4238011299 @default.
• W2076391217 cites W4322703265 @default.
• W2076391217 doi "https://doi.org/10.2310/7060.2004.19002" @default.
• W2076391217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15541221" @default.
• W2076391217 hasPublicationYear "2006" @default.
• W2076391217 type Work @default.
• W2076391217 sameAs 2076391217 @default.
• W2076391217 citedByCount "17" @default.
• W2076391217 countsByYear W20763912172013 @default.
• W2076391217 countsByYear W20763912172014 @default.
• W2076391217 countsByYear W20763912172015 @default.
• W2076391217 countsByYear W20763912172017 @default.
• W2076391217 countsByYear W20763912172018 @default.
• W2076391217 countsByYear W20763912172019 @default.
• W2076391217 countsByYear W20763912172023 @default.
• W2076391217 crossrefType "journal-article" @default.
• W2076391217 hasAuthorship W2076391217A5009880582 @default.
• W2076391217 hasAuthorship W2076391217A5023970736 @default.
• W2076391217 hasAuthorship W2076391217A5053578134 @default.
• W2076391217 hasAuthorship W2076391217A5069017206 @default.
• W2076391217 hasBestOaLocation W20763912171 @default.
• W2076391217 hasConcept C121332964 @default.
• W2076391217 hasConcept C12590561 @default.
• W2076391217 hasConcept C1276947 @default.
• W2076391217 hasConcept C159047783 @default.
• W2076391217 hasConcept C159654299 @default.
• W2076391217 hasConcept C203014093 @default.
• W2076391217 hasConcept C203165030 @default.
• W2076391217 hasConcept C22070199 @default.
• W2076391217 hasConcept C2775876817 @default.
• W2076391217 hasConcept C2776029263 @default.
• W2076391217 hasConcept C2780799908 @default.
• W2076391217 hasConcept C2780801004 @default.
• W2076391217 hasConcept C2780868878 @default.
• W2076391217 hasConcept C32611913 @default.
• W2076391217 hasConcept C71924100 @default.
• W2076391217 hasConceptScore W2076391217C121332964 @default.
• W2076391217 hasConceptScore W2076391217C12590561 @default.
• W2076391217 hasConceptScore W2076391217C1276947 @default.
• W2076391217 hasConceptScore W2076391217C159047783 @default.
• W2076391217 hasConceptScore W2076391217C159654299 @default.
• W2076391217 hasConceptScore W2076391217C203014093 @default.
• W2076391217 hasConceptScore W2076391217C203165030 @default.
• W2076391217 hasConceptScore W2076391217C22070199 @default.
• W2076391217 hasConceptScore W2076391217C2775876817 @default.
• W2076391217 hasConceptScore W2076391217C2776029263 @default.
• W2076391217 hasConceptScore W2076391217C2780799908 @default.
• W2076391217 hasConceptScore W2076391217C2780801004 @default.
• W2076391217 hasConceptScore W2076391217C2780868878 @default.
• W2076391217 hasConceptScore W2076391217C32611913 @default.
• W2076391217 hasConceptScore W2076391217C71924100 @default.
• W2076391217 hasIssue "4" @default.
• W2076391217 hasLocation W20763912171 @default.
• W2076391217 hasLocation W20763912172 @default.
• W2076391217 hasOpenAccess W2076391217 @default.
• W2076391217 hasPrimaryLocation W20763912171 @default.
• W2076391217 hasRelatedWork W1981371678 @default.
• W2076391217 hasRelatedWork W1995190108 @default.
• W2076391217 hasRelatedWork W2046558742 @default.
• W2076391217 hasRelatedWork W2056508934 @default.
• W2076391217 hasRelatedWork W2347291076 @default.
• W2076391217 hasRelatedWork W2347776527 @default.
• W2076391217 hasRelatedWork W2354916412 @default.

• next